Home > PS Ratio > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.35.

Share Price ₹87.3Apr 18,2024
Market Cap ₹206.9 Cr
Sales-TTM₹153.3 CrTTM-Standalone Results
Price/Sales1.35xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BAFNA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹206.9 Cr] as on Apr 18,2024

(/) Sales [ ₹153.3 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 1.35x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.35 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS


PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS

- BAFNA PHARMACEUTICALS 's latest p/e ratio is 1.35x.

- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.09x.

- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.

- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.05x.


How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BAFNA PHARMACEUTICALS 153.31.35206.9
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.67364,015.0
CIPLA LTD25,350.24.29108,809.0
DR REDDYS LABORATORIES LTD27,212.53.6599,408.7
ZYDUS LIFESCIENCES LTD19,024.24.9594,213.7
DIVIS LABORATORIES LTD7,492.813.1798,684.0
MANKIND PHARMA LTD9,946.39.6696,037.1
TORRENT PHARMACEUTICALS LTD10,474.08.2386,219.0
LUPIN LTD19,480.13.7372,621.1
AUROBINDO PHARMA LTD27,894.72.3465,326.3
ABBOTT INDIA LTD5,753.49.6255,366.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.35x
Max industry PS 13.17x
Median industry PS 4.95x
Average industry PS 6.24x



You may also like the below Video Courses